Type III prostatitis
Conditions
Interventions
Compound Jinqiancao Granules Group:Compound Jinqiancao Granules
Sponsors
Institute of Basic Research in Clinical Medicine China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1)It conforms to the diagnosis of type III prostatitis; 2) In traditional Chinese medicine it is diagnosed as damp-heat descending syndrome. 3)18 years old to 45 years old; 4)10 points =NIH-CPSI score =29 points; 5) Those who voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Patients with pelvic region pain and abnormal urination not caused by prostatitis such as urinary tract infections benign prostatic hyperplasia urinary calculi urethral stricture prostate tumors and other diseases; 2) Those who have used drugs or other related treatments for type III prostatitis within the past two weeks; 3) Patients with severe primary diseases Including but not limited to severe diarrhea uncontrolled cardiovascular and cerebrovascular diseases (such as unstable angina pectoris severe arrhythmia acute stroke etc.) decompensated liver disease (ALT/AST > 1.5 times the upper limit of normal) severe renal insufficiency (serum creatinine > the upper limit of normal) uncontrolled malignant tumors active immune system diseases and hematological diseases (such as severe anemia) (Coagulation disorders) and other diseases that researchers consider may affect the safety of the study; 4) Those with allergic constitutions a history of allergy to the ingredients of this product and those who cannot tolerate the drug; 5) Those with severe mental illnesses (such as major depression schizophrenia etc.); 6) Patients in the preconception period; 7) Have participated in drug clinical research within the past month; 8) The researcher considers it inappropriate to participate in clinical research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The reduction value of NIH-CPSI score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Count of white blood cells and lecithin bodies in prostatic fluid;TCM symptom score; | — |
Countries
China
Contacts
Public ContactXie Yanming
Institute Of Basic Research In Clinical MedicineChina Academy Of Chinese Medical Sciences
Outcome results
None listed